Rocket Pharmaceuticals, Inc. Common Stock

RCKT XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

320M

Short interest (May 15)

19.2%

Net Short (Jun 03 ): 0.0%

Borrow Fee

0.65%

↑ 33.2%

Available Shares

↓ 5.8%

Price Chart

Company Overview

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001281895

Asset Type: CS

Market Data

Market Cap: $315,569,356

Employees: 202

Status: Active

Short Interest

Current Borrow Fee 0.65%

Range: 0.46% - 0.65%

Available Shares 5M

Range: 1.4M - 5.2M

Recent Changes

Fee Change: ↓ 9.5%

Available Change: ↓ 4.2%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime